Drug
Dsp 0509
Dsp 0509: highest development phase Phase 1/2, developed by Sumitomo Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Sumitomo Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| DSP-0509 NCT03416335 | Phase 1/2 | Neoplasms |
Latest
No recent events.
Follow Dsp 0509 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.